Strategic management of keloid disease in ethnic skin: A structured approach supported by the emerging literature

British Journal of Dermatology

Volumn 169, Issue SUPPL. 3, 2013, Pages 71-81

  Ud Din, S ^a,b   Bayat, Ardeshir ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BLEOMYCIN; CORTICOSTEROID; DEXAMETHASONE; FLUOROURACIL; HYDROCORTISONE ACETATE; IMIQUIMOD; INTERFERON; METHYLPREDNISOLONE; SILICONE GEL; STEROID; TRIAMCINOLONE ACETONIDE;

CLINICAL PRACTICE; COMPRESSION; CRYOSURGERY; CRYOTHERAPY; ELECTROSTIMULATION; FOLLOW UP; HERITABILITY; HUMAN; HYPERPIGMENTATION; HYPERTROPHIC SCAR; KELOID; LOW LEVEL LASER THERAPY; OCCUPATIONAL THERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; SPLINT; ULCER;

AMINOQUINOLINES; BLEOMYCIN; CRYOSURGERY; DERMATOLOGIC AGENTS; ELECTRIC STIMULATION; FLUOROURACIL; HUMANS; INJECTIONS, INTRALESIONAL; KELOID; MEDICAL HISTORY TAKING; PHOTOCHEMOTHERAPY; PHYSICAL EXAMINATION; RECURRENCE; SILICONE GELS; STEROIDS;

EID: 84891489391     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12588     Document Type: Review

References (96)

1. Mrowietz U, Seifert O. Keloid scarring: new treatments ahead. Actas Dermosifiliogr 2009; 100:75-83.
2. Murray JC. Keloids and hypertrophic scars. J Clin Dermatol 1994; 12:27.
3. Bayat A, McGrouther D, Ferguson M. Skin scarring. BMJ 2003; 326:88-92.
4. Al-Attar A, Mess S, Thomassen JM et al. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006; 117:286-300.
5. Datubo-Brown D. Keloids: a review of the literature. Br J Plast Surg 1990; 43:70-7.
6. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006; 297:433-8.
7. Brown JJ, Bayat A. Genetic susceptibility to raised dermal scarring. Br J Dermatol 2006; 161:8-18.
8. Ehrlich HP, Desmoulière A, Diegelmann RF et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994; 145:105-13.
9. Bran GM, Goessler UR, Hormann K et al. Keloids: current concepts of pathogenesis (review). Int J Mol Med 2009; 24:283-93.
10. Bayat A, McGrouther DA. Clinical management of skin scarring. Skinmed 2005; 4:165-73.
11. Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician 2009; 80:253-60.
12. Chike-Obi CJ, Cole PD, Brissett AE. Keloids: pathogenesis, clinical features, and management. Semin Plast Surg 2009; 23:178-84.
13. Peacock EE Jr, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J 1970; 63:755- 60.
14. Urioste SS, Arndt KA, Dover JS. Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg 1999; 18:159- 71.
15. Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 2010; 125:557-68.
16. Kelly PA. Medical and surgical therapies for keloids. Dermatol Ther 2004; 17:212-8.
17. Berman B, Bieley HC. Keloids. J Am Acad Dermatol 1995; 33:117- 23.
18. Mustoe TA, Cooter RD, Gold MH. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110:560- 71.
19. Siemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006; 18:396-402.
20. Aarabi S, Bhatt K, Shi Y et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 2007; 21:3250-61.
21. O'Brien L, Pandit A Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2006; 2006:CD003826.
22. Occleston N, Melcalfe A, Boanas A et al. Therapeutic improvement of scarring: mechanism of scarless and scar-forming healing and approaches to discovery of new treatments. Dermatol Res Pract 2010; 2010:405262.
23. Careta MF, Fortes AC, Messina MC, Maruta CW. Combined treatment of earlobe keloids with shaving, cryosurgery, and intralesional steroid injection: a 1-year follow-up. Dermatol Surg 2013; 39:734-8.
24. Granstein RD, Rook A, Flotte TJ et al. A controlled trial of intralesional recombinant interferon-c in the treatment of keloidal scarring Clinical and histologic findings. Arch Dermatol 1990; 126:1295-302.
25. Copcu E, Sivrioglu N, Oztan Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J Burn Care Rehabil 2004; 25:1-7.
26. Nicoletti G, de Francesco F, Mele CM et al. Clinical and histologic effects from CO2 laser treatment of keloids. Lasers Med Sci 2013; 28:957-64.
27. Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon 2007; 5:175-80.
28. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994; 30:506-7.
29. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 2004; 45:140-3.
30. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992; 45:374-9.
31. España A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001; 27:23-7.
32. Froelich K, Staudenmaier R, Kleinsasser N, Hagen R. Therapy of auricular keloids: review of different treatment modalities and proposal for a therapeutic algorithm. Eur Arch Otorhinolaryngol 2007; 264:1497-508.
33. Ud-Din S, Thomas G, Morris J, Bayat A. Photodynamic therapy: an innovative approach to the treatment of keloid disease evaluated using subjective and objective non-invasive tools. Arch Dermatol Res 2013; 305:205-14.
34. Perry D, Colthurst J, Giddings P et al. Treatment of symptomatic abnormal skin scars with electrical stimulation. J Wound Care 2010; 19:447-53.
35. Poochareon VN, Berman B. New therapies for the management of keloids. J Craniofac Surg 2003; 14:654-7.
36. McCoy BJ, Diegelmann RF, Cohen IK. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 1980; 163:216-22.
37. Wu WS, Wang FS, Yang KD et al. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 2006; 126:1264-71.
38. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5- fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 2006; 32:907-15.
39. Koc E, Arca E, Surucu B, Kurumlu Z. An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids. Dermatol Surg 2008; 34:1507-14.
40. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars. Comparison among intralesional corticosteroid, 5-fluorouracil, and 585 nm flashlamp-pumped pulsed dye laser treatments. Arch Dermatol 2002; 138:1149-55.
41. Gauglitz GG, Korting HC, Pavicic T et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17:113-25.
42. Sadeghinia A, Sadeghinia S. Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids. Dermatol Surg 2012; 38:104-9.
43. Robles D, Moore E, Draznin M, Berg D. Keloids: pathophysiology and management. Dermatol Online J 2007; 13:9.
44. Cruz NI, Korchin L. Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg 1994; 33:401-5.
45. Kill J. Keloids treated with topical injections of triamcinolone acetonide (kenalog): immediate and long-term results. Scand J Plast Reconstr Surg 1977; 11:169-72.
46. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 1994; 130:498-501.
47. Ud-Din S, Bowring A, Derbyshire B et al. Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease. Arch Dermatol Res 2013; 305:423-32.
48. Gold MH, Foster TD, Adair MA et al. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following surgical procedure in an office setting. Dermatol Surg 2001; 27:641-4.
49. Sawada Y, Sone K. Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg 1992; 45:599-603.
50. Chang CC, Kuo YF, Chiu HC et al. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res 1995; 59:705-11.
51. de Oliveira GV, Nunes TA, Magna LA et al. Silicone versus nonsilicone gel dressings: a controlled trial. Dermatol Surg 2001; 27:721-6.
52. Durani P, Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg 2008; 61:4-17.
53. Uppal RS, Khan U, Kakar S et al. The effects of a single dose of 5- fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg 2001; 108:1218-24.
54. de Waard JW, de Man BM, Wobbes T et al. Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil. Eur J Cancer 1998; 34:162-7.
55. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004; 30:54-6. discussion 56-7.
56. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002; 204:130-2.
57. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol 2005; 52:474-9.
58. Khare N, Patil SB. A novel approach for management of ear keloids: results of excision combined with 5-fluorouracil injection. J Plast Reconstr Aesthet Surg 2012; 65:315-17.
59. Hatamipour E, Mehrabi S, Hatamipour M, Ghafarian Shirazi HR. Effects of combined intralesional 5-fluorouracil and topical silicone in prevention of keloids: a double blind randomized clinical trial study. Acta Med Iran 2011; 49:127-30.
60. Troiano M, Simeone A, Scaramuzzi G et al. Giant keloid of left buttock treated with post-excisional radiotherapy. J Radiol Case Rep 2011; 5:8-15.
61. Norris JE. Superficial X-ray therapy in keloid management: a retrospective study of 24 cases and literature review. Plast Reconstr Surg 1995; 95:1051-5.
62. Doornbos JF, Stoffel TJ, Hass AC et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys 1990; 18:833-9.
63. Wagner W, Alfrink M, Micke O et al. Results of prophylactic irradiation in patients with resected keloids: a retrospective analysis. Acta Oncol 2000; 39:217-20.
64. Klumpar DI, Murray JC, Anscher M. Keloids treated with excision followed by radiation therapy. J Am Acad Dermatol 1994; 31:225- 31.
65. Ragoowansi R, Cornes PG, Moss AL, Glees JP. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg 2003; 111:1853-9.
66. Maarouf M, Schleicher U, Schmachtenberg A, Ammon J. Radiotherapy in the management of keloids. Clinical experience with electron beam irradiation and comparison with X-ray therapy. Strahlenther Onkol 2002; 178:330-5.
67. Sclafani AP, Gordon L, Chadha M, Romo T III. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg 1996; 22:569-74.
68. Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg 2006; 32:1023-9, discussion 1029-30.
69. Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 2002; 47:209-11.
70. Martin-Garcia RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg 2005; 31:1394-8.
71. Stashower ME. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatol Surg 2006; 32:380- 6.
72. Cacao FM, Tanaka V, Messina MC. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids. Dermatol Surg 2009; 35:629-33.
73. Christensen E, Warloe T, Kroon S et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2010; 24:505-12.
74. Mendoza J, Sebastian A, Allan E et al. Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion. Arch Dermatol Res 2012; 304:549-62.
75. Nie Z, Bayat A, Behzad F, Rhodes LE. Positive response of a recurrent keloid scar to topical methyl aminolevulinate-photodynamic therapy. Photodermatol Photoimmunol Photomed 2010; 26:330-2.
76. Sebastian A, Syed F, McGrouther DA et al. A novel in vitro assay for electrophysiological research on human skin fibroblasts: degenerate electrical waves downregulate collagen I expression in keloid fibroblasts. Exp Dermatol 2011; 20:64-8.
77. Ud-Din S, Giddings P, Colthurst J et al. Significant reduction of symptoms of scarring with electrical stimulation: evaluated with subjective and objective assessment tools. Wounds 2013; 25:212- 224.
78. Sebastian A, Allan E, Allan D et al. Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy. J Dermatol Sci 2011; 64:174-84.
79. Tziotzios C, Profyris C, Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics. Part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol 2012; 66:13-24.
80. Chan KY, Lau CL, Adeeb SM et al. A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg 2005; 116:1013-20.
81. de Giorgi V. The use of silicone gel in the treatment of fresh surgical scars: a randomized study. Clin Exp Dermatol 2009; 34:688-93.
82. Majan JI. Evaluation of a self-adherent soft silicone dressing for the treatment of hypertrophic postoperative scars. J Wound Care 2006; 15:193-6.
83. Niessen FB, Spauwen PH, Robinson PH et al. The use of silicone occlusive sheeting (Sil-K) and silicone occlusive gel (Epiderm) in the prevention of hypertrophic scar formation. Plast Reconstr Surg 1998; 102:1962-72.
84. Akaishi S, Akimoto M, Hyakusoku H, Ogawa R. The tensile reduction effects of silicone gel sheeting. Plast Reconstr Surg 2010; 126: e109-11.
85. Rauscher GE, Kolmer WL. Treatment of recurrent earlobe keloids. Cutis 1986; 37:67-8.
86. Meyer M, McGrouther D. A study relating wound tension to scar morphology in the pre-sternal scar using Langers technique. Br J Plast Surg 1991; 44:291-4.
87. Yencha MW, Oberman JP. Combined therapy in the treatment of auricular keloids. Ear Nose Throat J 2006; 85:93-4.
88. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg 2003; 111:1841-52.
89. Barara M, Mendiratta V, Chander R. Cryotherapy in treatment of keloids: evaluation of factors affecting treatment outcome. J Cutan Aesthet Surg 2012; 5:185-9.
90. Niessen F, Spauwen P, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104:1435-8.
91. Bloemen MC, van der Veer WM, Ulrich MM et al. Prevention and curative management of hypertrophic scar formation. Burns 2009; 35:463-75.
92. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg 2008; 206:731-41.
93. Reish RG, Eriksson E. Scars: a review of emerging and currently available therapies. Plast Reconstr Surg 2008; 122:1068-78.
94. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002; 46:63-97.
95. van Zuijlen PP, Angeles AP, Kreis RW et al. Scar assessment tools: implications for current research. Plast Reconstr Surg 2002; 109:1108-22.
96. Bagabir R, Syed F, Paus R, Bayat A. Long-term organ culture of keloid disease tissue. Exp Dermatol 2012; 21:376-81.